| |
| |
|
| Insider
Information: |
Care Capital Offshore Investments Iii Lp |
| Relationship: |
10% Owner |
| City: |
Princeton |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
42,010,090 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$76,511,863 |
|
|
| Total
Shares |
42,010,090 |
|
|
| Total
Value |
$76,511,863 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Nephrogenex, Inc. |
NRX |
Director, 10% Owner |
2014-02-14 |
0 |
2014-02-14 |
4,241,097 |
Premium* |
|
|
Agile Therapeutics Inc |
AGRX |
10% Owner |
2014-05-29 |
0 |
2014-05-29 |
3,010,189 |
Premium* |
|
|
Minerva Neurosciences, Inc. |
NERV |
10% Owner |
|
0 |
2015-03-18 |
1,662,592 |
Premium* |
|
|
Rocket Pharmaceuticals |
RCKT |
10% Owner |
|
0 |
2015-02-23 |
2,277,139 |
Premium* |
|
|
Colucid Pharmaceuticals, Inc. |
CLCD |
10% Owner |
2015-05-11 |
0 |
2015-05-11 |
25,403 |
Premium* |
|
|
Vaxart Inc |
VXRT |
10% Owner |
2018-02-13 |
0 |
2018-02-13 |
30,793,670 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
20 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VXRT |
Vaxart Inc |
10% Owner |
– – • |
2018-02-13 |
4 |
A |
$0.00 |
$0 |
I/I |
30,793,670 |
30,793,670 |
0 |
- |
|
| CLCD |
Colucid Pharmaceuticals, ... |
10% Owner |
– – • |
2015-05-11 |
4 |
A |
$0.00 |
$0 |
I/I |
1,545,539 |
25,403 |
0 |
- |
|
| NERV |
Minerva Neurosciences, In... |
10% Owner |
– – • |
2015-03-18 |
4 |
S |
$5.75 |
$6,941,875 |
I/I |
(1,206,700) |
1,662,592 |
0 |
- |
|
| RCKT |
Rocket Pharmaceuticals |
10% Owner |
– – • |
2015-02-23 |
4 |
B |
$6.00 |
$3,622,992 |
I/I |
603,832 |
2,277,139 |
1.5 |
- |
|
| RCKT |
Rocket Pharmaceuticals |
10% Owner |
– – • |
2015-02-23 |
4 |
A |
$0.00 |
$0 |
I/I |
1,458,205 |
1,673,307 |
0 |
- |
|
| RCKT |
Rocket Pharmaceuticals |
10% Owner |
– – • |
2015-02-17 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
215,102 |
|
- |
|
| NERV |
Minerva Neurosciences, In... |
10% Owner |
– – • |
2015-01-26 |
4 |
S |
$5.02 |
$116,017 |
I/I |
(23,111) |
2,869,292 |
0 |
- |
|
| NERV |
Minerva Neurosciences, In... |
10% Owner |
– – • |
2015-01-23 |
4 |
S |
$5.14 |
$325,383 |
I/I |
(63,304) |
2,892,403 |
0 |
- |
|
| NERV |
Minerva Neurosciences, In... |
10% Owner |
– – • |
2015-01-22 |
4 |
S |
$5.11 |
$2,022,012 |
I/I |
(395,697) |
2,955,707 |
0 |
- |
|
| NERV |
Minerva Neurosciences, In... |
10% Owner |
– – • |
2015-01-08 |
4 |
S |
$5.66 |
$399,930 |
I/I |
(70,659) |
3,351,404 |
0 |
- |
|
| NERV |
Minerva Neurosciences, In... |
10% Owner |
– – • |
2015-01-07 |
4 |
S |
$5.85 |
$376,026 |
I/I |
(64,278) |
3,422,063 |
0 |
- |
|
| NERV |
Minerva Neurosciences, In... |
10% Owner |
– – • |
2015-01-06 |
4 |
S |
$7.94 |
$3,151,156 |
I/I |
(396,871) |
3,486,341 |
0 |
- |
|
| NERV |
Minerva Neurosciences, In... |
10% Owner |
– – • |
2014-07-07 |
4 |
B |
$6.00 |
$4,425,000 |
I/I |
737,500 |
3,883,212 |
1.5 |
- |
|
| NERV |
Minerva Neurosciences, In... |
10% Owner |
– – • |
2014-07-07 |
4 |
OE |
$6.00 |
$1,056,006 |
I/I |
176,001 |
3,145,712 |
0 |
- |
|
| NERV |
Minerva Neurosciences, In... |
10% Owner |
– – • |
2014-06-30 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,969,711 |
|
- |
|
| AGRX |
Agile Therapeutics Inc |
10% Owner |
– – • |
2014-05-29 |
4 |
A |
$0.00 |
$0 |
I/I |
2,510,189 |
2,510,189 |
0 |
- |
|
| AGRX |
Agile Therapeutics Inc |
10% Owner |
– – • |
2014-05-29 |
4 |
B |
$6.00 |
$3,000,000 |
I/I |
500,000 |
3,010,189 |
1.5 |
- |
|
| NRX |
Nephrogenex, Inc. |
Director |
– • • |
2014-02-14 |
4 |
B |
$12.00 |
$9,480,000 |
I/I |
790,000 |
4,241,097 |
2.25 |
- |
|
| NRX |
Nephrogenex, Inc. |
Director |
– • • |
2014-02-14 |
4 |
A |
$0.00 |
$0 |
I/I |
412,592 |
3,451,097 |
0 |
- |
|
| NRX |
Nephrogenex, Inc. |
Director |
– • • |
2014-02-14 |
4 |
A |
$0.00 |
$0 |
I/I |
3,038,505 |
3,038,505 |
0 |
- |
|
20 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
